000 | 00800 a2200229 4500 | ||
---|---|---|---|
005 | 20250514010648.0 | ||
264 | 0 | _c20020103 | |
008 | 200201s 0 0 eng d | ||
022 | _a0890-9091 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, H X | |
245 | 0 | 0 |
_aClinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab. _h[electronic resource] |
260 |
_bOncology (Williston Park, N.Y.) _cAug 2001 |
||
300 |
_a1017, 1020, 1023-6 p. _bdigital |
||
500 | _aPublication Type: Directory | ||
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
700 | 1 | _aGore-Langton, R E | |
700 | 1 | _aCheson, B D | |
773 | 0 |
_tOncology (Williston Park, N.Y.) _gvol. 15 _gno. 8 _gp. 1017, 1020, 1023-6 |
|
999 |
_c11471619 _d11471619 |